For patients  /  Lupus
Lupus condition hub

Lupus clinical trials, explained for patients.

How trials work, what eligibility rules actually mean, what's new in lupus research this year, and where to find support along the way. Built with resources from Lupus Canada and the lupus community.

Free, private, no obligation. Purple is the international colour of lupus awareness, so this page wears it too.

Reasons for hope

What's new in lupus research this year

Lupus research is moving. Three developments from 2026 worth knowing about, in plain language:

Phase 3 · AMETHYST trial

Litifilimab

FDA Breakthrough Therapy Designation, January 2026

A monoclonal antibody for cutaneous lupus erythematosus, the form of lupus that affects the skin and currently has no specifically approved treatments. The breakthrough designation is meant to speed up its development and review.

Phase 2 · WILLOW study

Enpatoran

Results published in The Lancet, May 2026

A first-of-its-kind oral pill that showed strong effectiveness for lupus patients with skin involvement. A pill matters: many current lupus treatments require infusions or injections.

Phase 1 · OUTRACE SLE study

CLN-978

Early remission data presented at EULAR 2026

An investigational T-cell engager that showed clinical benefit, including remissions, after a single dose in people with refractory systemic lupus, meaning lupus that hasn't responded to existing treatments.

The basics

How lupus clinical trials work

Clinical trials move through phases, and each one tests something different before a treatment can reach patients broadly:

Phase 1 Roughly 20–100 people

A small group tests safety, tolerability, and dosing.

Phase 2 100–300 people with lupus

Tests whether the treatment actually works, while continuing to monitor safety and side effects.

Phase 3 300 to several thousand

A large, diverse group confirms effectiveness, often comparing the new treatment to a standard treatment or placebo. Usually the step required before regulatory approval.

Phase 4 After approval

The treatment is monitored in real-world use for long-term safety and rare side effects.

In every phase, three things stay constant: an informed consent process (a full explanation of purpose, risks, and benefits before you agree to participate), regular monitoring visits, and your right to withdraw at any time.
Decoding the fine print

What eligibility criteria mean

Every trial lists two kinds of rules. Here's how to read them:

Inclusion criteria

Traits you must have to qualify
  • A confirmed lupus diagnosis
  • A certain disease activity level
  • A specific age range
  • Specific prior treatments

Exclusion criteria

Traits that rule you out
  • Certain other health conditions
  • Certain current medications
  • Pregnancy
  • Lab values outside a safe range
Worth repeating: these rules exist to protect participant safety and to keep the study's results reliable. They are not a judgment on you, and not qualifying for one trial doesn't mean you won't qualify for another.
You're not doing this alone

Trusted lupus resources

Support for the whole journey: learning, funding, and community.

Learn from Lupus Canada

Plain-language education from Canada's national lupus organization
  • What Is a Lupus Clinical Trial? Overview of how trials work, eligibility, informed consent, benefits, and risks.
  • Everything Lupus Resource Hub Searchable articles, research updates, and support tools, filterable by topic including Research & Clinical Trials.
  • Canadian Lupus Research Updates on Canadian studies and funded research.
  • Provincial Lupus Organizations Directory Regional groups that post local trial and survey opportunities.

Financial support

Help with medication and treatment costs
  • Lupus Canada — Government Support Programs CANADA Overview of Canadian disability and health benefit programs relevant to lupus patients.
  • 211 Canada CANADA Free, confidential 24/7 referral service connecting people to local health, social, and financial support services.
  • PAN Foundation — SLE Fund US Helps cover medication copay costs for eligible patients in the United States.
  • HealthWell Foundation — SLE Fund US Copay and premium assistance; opens and closes based on available funding.
  • Lupus Research Alliance — Financial Resources Curated list of assistance programs for people with lupus.

Community & emotional support

People who understand what you're living with
  • BC Lupus Society Weekly virtual support group meetings, Mondays and Wednesdays, open to patients across Canada.
  • Lupus Ontario — Support Online and in-person support groups for sharing self-management strategies.
  • Lupus Canada — Self-Help Tools Managing symptoms, fatigue, and day-to-day life with lupus.
  • Lupus Canada — Talking About Lupus Guidance for discussing a diagnosis with family, employers, and friends.
  • Lupus Canada — Lifestyle & Wellness Practical wellness content alongside emotional wellbeing tips.

Not sure where to start? Call Lupus Canada.

They can help direct you to the right provincial or trial resource.

Before your first call

Tips for getting started

  • Bring a current medication and symptom list to any trial screening call. It's the first thing coordinators ask about, and having it ready makes the call faster and more accurate.
  • Ask three questions before enrolling: Is travel or reimbursement support available? Is there a placebo arm, and what would that mean for me? What happens after the trial ends?
  • Talk to your rheumatologist. These are informational resources, not medical advice. Your rheumatologist knows your history and can help you weigh whether a specific trial makes sense for you.
The research updates and resources on this page are for information only and are not medical advice. Always talk to a rheumatologist before enrolling in any trial.

See which lupus trials fit your situation

Answer a few questions about your lupus, your treatments, and where you live. We'll show you what's recruiting, in plain language.

Free for patients. Private. No obligation at any step.